These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 22212513)

  • 1. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study.
    Dulery R; Salleron J; Dewilde A; Rossignol J; Boyle EM; Gay J; de Berranger E; Coiteux V; Jouet JP; Duhamel A; Yakoub-Agha I
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1080-9. PubMed ID: 22212513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT.
    de Pagter PJ; Schuurman R; Keukens L; Schutten M; Cornelissen JJ; van Baarle D; Fries E; Sanders EA; Minnema MC; van der Holt BR; Meijer E; Boelens JJ
    Bone Marrow Transplant; 2013 Nov; 48(11):1460-4. PubMed ID: 23771003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.
    Aoki J; Numata A; Yamamoto E; Fujii E; Tanaka M; Kanamori H
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2017-22. PubMed ID: 26226409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
    Schönberger S; Meisel R; Adams O; Pufal Y; Laws HJ; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1428-35. PubMed ID: 20399877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for human herpesvirus 6 reactivation and its relationship with syndrome of inappropriate antidiuretic hormone secretion after stem cell transplantation in pediatric patients.
    Toriumi N; Kobayashi R; Yoshida M; Iguchi A; Sarashina T; Okubo H; Suzuki D; Sano H; Ogata M; Azuma H
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):379-83. PubMed ID: 23929317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infections with human herpesvirus 6 variant B delay platelet engraftment after allogeneic haematopoietic stem cell transplantation.
    Radonić A; Oswald O; Thulke S; Brockhaus N; Nitsche A; Siegert W; Schetelig J
    Br J Haematol; 2005 Nov; 131(4):480-2. PubMed ID: 16281938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complex relationship between human herpesvirus 6 and acute graft-versus-host disease.
    Pichereau C; Desseaux K; Janin A; Scieux C; Peffault de Latour R; Xhaard A; Robin M; Ribaud P; Agbalika F; Chevret S; Socié G
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):141-4. PubMed ID: 21801705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of Human Herpes Virus-6 After Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association With Severity of Acute Graft-Versus-Host Disease.
    Verhoeven DH; Claas EC; Jol-van der Zijde CM; Thijssen JC; Lankester AC; Bredius RG; Putter H; Kroes AC; Egeler RM; Schilham MW; van Tol MJ
    Pediatr Infect Dis J; 2015 Oct; 34(10):1118-27. PubMed ID: 26132825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First analysis of human herpesvirus 6T-cell responses: specific boosting after HHV6 reactivation in stem cell transplantation recipients.
    de Pagter AP; Boelens JJ; Scherrenburg J; Vroom-de Blank T; Tesselaar K; Nanlohy N; Sanders EA; Schuurman R; van Baarle D
    Clin Immunol; 2012 Sep; 144(3):179-89. PubMed ID: 22820131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation.
    Tokimasa S; Hara J; Osugi Y; Ohta H; Matsuda Y; Fujisaki H; Sawada A; Kim JY; Sashihara J; Amou K; Miyagawa H; Tanaka-Taya K; Yamanishi K; Okada S
    Bone Marrow Transplant; 2002 Apr; 29(7):595-8. PubMed ID: 11979309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients.
    Ljungman P; Wang FZ; Clark DA; Emery VC; Remberger M; Ringdén O; Linde A
    Br J Haematol; 2000 Dec; 111(3):774-81. PubMed ID: 11122137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship among human herpesvirus 6 reactivation, serum interleukin 10 levels, and rash/graft-versus-host disease after allogeneic stem cell transplantation.
    Kitamura K; Asada H; Iida H; Fukumoto T; Kobayashi N; Niizeki H; Morii T; Kimura H; Miyagawa S
    J Am Acad Dermatol; 2008 May; 58(5):802-9. PubMed ID: 18367292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults.
    Le Bourgeois A; Labopin M; Guillaume T; Delaunay J; Foucher Y; Tessoulin B; Malard F; Ayari S; Peterlin P; Derenne S; Herry P; Cesbron A; Gagne K; Lodé L; Illiaquer M; Imbert-Marcille BM; Le Gouill S; Moreau P; Mohty M; Chevallier P
    Exp Hematol; 2014 Nov; 42(11):945-54. PubMed ID: 25072620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?
    Betts BC; Young JA; Ustun C; Cao Q; Weisdorf DJ
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1562-8. PubMed ID: 21549850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation.
    Jeulin H; Agrinier N; Guery M; Salmon A; Clément L; Bordigoni P; Venard V
    Transplantation; 2013 May; 95(10):1292-8. PubMed ID: 23514960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Herpesvirus-6 cytopathic inclusions: an exceptional and recognizable finding on skin biopsy during HHV6 reactivation after autologous stem-cell transplantation.
    Roux J; Battistella M; Fornecker L; Legoff J; Deau B; Houhou N; Bouaziz JD; Thieblemont C; Janin A
    Am J Dermatopathol; 2012 Aug; 34(6):e73-6. PubMed ID: 22576078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.